The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression

Archives of General Psychiatry

Volumn 55, Issue 12, 1998, Pages 1128-1132

  Melfi, Catherine A ^a,b   Chawla, Anita J ^c   Croghan, Thomas W ^a,b   Hanna, Mark P ^b   Kennedy, Sean ^d   Sredl, Kate ^d  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDSTAT GROUP   (United States)

^d MEDSTAT Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; ELECTROCONVULSIVE THERAPY; EMERGENCY TREATMENT; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RECURRENT DISEASE; RELAPSE; SUICIDE ATTEMPT;

EID: 0031737512     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.12.1128     Document Type: Article

References (20)

1. Consensus Development Conference Statement (NIMH/NIH). Mood disorders. Am J Psychiatry. 1985;142:469-475.
2. Depression Guideline Panel. Treatment of major depression. In: Depression in Primary Care. Vol 2. Clinical Practice Guideline No. 5. Rockville, Md: US Dept of Health and Human Services, Public Health Service, and Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0550.
3. Sturm R, Wells KB. How can care for depression become more cost-effective? JAMA. 1995;273:51-58.
4. Mintz J, Mintz LI, Arruda MJ, Hwang SS. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry. 1992;49:761-768.
5. American Psychiatric Association. Practice guidelines for major depressive disorder in adults. Am J Psychiatry. 1993;150:1-26.
6. Lewinsohn PM, Zeiss AM, Duncan EM. Probability of relapse after recovery from an episode of depression. J Abnorm Psychol. 1989;98:107-116.
7. Keller MB, Lavori PW, Lewis CE, Klerman GL. Predictors of relapse in major depressive disorder. JAMA. 1983;250:3299-3304.
8. Ramana R, Paykel ES, Cooper Z, Hayhurst H, Saxty M, Surtees PG. Remission and relapse in major depression. Psychol Med. 1995;25:1161-1170.
9. Keller MB. The naturalistic course of anxiety and depressive disorders. Clin Neuropharmacol. 1992:15(suppl 1, pt A):171A-173A.
10. Rouillon F, Serrurier MS, Miller HD, Gerard M-J. Prophylactic efficacy of maprotiline on unipolar depression relapse. J Clin Psychiatry. 1991;52:423-431.
11. Frank E, Kupfer D, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1990;47:1093-1099.
12. Old Age Depression Interest Group. How long should the elderly take antidepressants? Br J Psychiatry. 1993;162:175-182.
13. Prien RF, Kupfer DJ. Continuation of drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry. 1986;143:18-23.
14. Katon W, Von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992;30:67-76.
15. Simon G, Ormel J, VonKorff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry. 1995;152:352-357.
16. Croghan TW, Lair TJ, Engelhart L, Crown WE, Copley-Merriman C, Melfi CA, Obenchain RL, Buesching DP. The effect of antidepressant medication on health care utilization and cost in primary care. Psychiatr Serv. 1997;48:1420-1426.
17. Maj M, Vletro F, Pirozzi R, Lobrace S, Magliano L. Pattern of recurrence of illness after recovery of an episode of major depression: a prospective study. Am J Psychiatry. 1992;149:795-800.
18. Wingert TD, Kralewski JE, Linguist TJ, Knutson DJ. Constructing episodes of care from encounter and claims data. Inquiry. 1995;32:430-443.
19. Hornbrook MC, Hurtado AV, Johnson RE. Health care episodes. Med Care Rev. 1985;42:163-219.
20. Kessler R McGonagle K, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8-19.